# Aura Biosciences Posts $0.29 GAAP Loss Per Share for Q3 2026

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/52924
Published: 2026-11-10T08:28:23.000Z
Updated: 2026-11-10T08:28:23.000Z
Section: Business

> The company had $297.2 million in cash, cash equivalents and marketable securities as of Sept. 30 and said it believes those resources can fund operations into the first half of 2029.

Aura Biosciences, Inc. posted a GAAP loss of $0.29 per share for the third quarter of 2026. Its cash, cash equivalents and marketable securities totaled $297.2 million as of Sept. 30.

The company said it believes those resources are sufficient to fund operations into the first half of 2029.